4.5 Article

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS CONFERENCE ON OBESITY: BUILDING AN EVIDENCE BASE FOR COMPREHENSIVE ACTION

期刊

ENDOCRINE PRACTICE
卷 20, 期 9, 页码 956-976

出版社

ELSEVIER INC
DOI: 10.4158/EP14279.CS

关键词

-

资金

  1. Astra Zeneca
  2. Merck Co., Inc.
  3. Weight Watchers International, Inc.
  4. Sanofi US
  5. Eisai Inc.
  6. Novo Nordisk
  7. AstraZeneca
  8. Boehringer Ingelheim GmbH
  9. MannKind Corporation
  10. Takeda Pharmaceutical Company Limited
  11. Eli Lilly and Company
  12. Janssen Pharmaceuticals, Inc.
  13. Bristol - Myers Squibb Company
  14. GlaxoSmithKline
  15. Amgen Inc.
  16. Gilead
  17. Intarcia Therapeutics, Inc.
  18. Lexicon Pharmaceuticals, Inc.
  19. Charles E. Schmidt College of Medicine at Florida Atlantic University (FAU)
  20. Bayer AG
  21. British Heart Foundation
  22. Cadila Pharmaceuticals Limited
  23. Canadian Institutes of Health
  24. Wellcome Trust
  25. U.S. Food and Drug Administration
  26. National Institutes of Health
  27. UpToDate, Inc.
  28. Stryker Corporation
  29. Novartis AG

向作者/读者索取更多资源

Objective/Methods: The American Association of Clinical Endocrinologists/American College of Endocrinology Consensus conference on obesity: building an evidence base for comprehensive action convened March 23-25, 2014, in Washington, D.C. The premise of the conference was that by bringing together stakeholders in U.S. obesity care, representing the biomedical and public health models, new information would emerge to formulate actionable recommendations. Results: Key conference findings include 5 affirmed and 8 emergent concepts. These concepts include the need for a medically meaningful and actionable diagnosis of obesity, research that evaluates and refines a complications-centric clinical approach to obesity, the need for a better understanding of reimbursement mechanisms and the value associated with obesity prevention and management, increased nutrition and obesity education, and enhanced public awareness and health literacy. Conclusion: Next steps include deriving a more robust medical definition of obesity, translation of the affirmed and emergent concepts into actionable recommendations in the interests of patients with obesity, and developing logistics for effective implementation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据